Rxsight Inc (RXST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 139,927 | 89,077 | 49,005 | 22,593 | 14,678 |
| Cost of Goods | 40,984 | 35,312 | 27,677 | 18,076 | 12,973 |
| Gross Profit | 98,943 | 53,765 | 21,328 | 4,517 | 1,705 |
| Operating Expenses | 136,785 | 104,162 | 85,323 | 57,380 | 38,076 |
| Operating Income | -36,858 | -50,085 | -63,318 | -52,787 | -35,412 |
| Interest Expense | 21 | 3,308 | 4,946 | 3,682 | 510 |
| Other Income | 9,474 | 4,805 | 1,517 | 7,789 | 63,554 |
| Pre-tax Income | -27,405 | -48,588 | -66,747 | -48,680 | 27,632 |
| Income Tax | 50 | 20 | 9 | 8 | 57 |
| Net Income Continuous | -27,455 | -48,608 | -66,756 | -48,688 | 27,575 |
| Net Income | $-27,455 | $-48,608 | $-66,756 | $-48,688 | $27,575 |
| EPS Basic Total Ops | -0.71 | -1.41 | -2.41 | -3.57 | 0.91 |
| EPS Basic Continuous Ops | -0.71 | -1.41 | -2.41 | -3.57 | 7.44 |
| EPS Diluted Total Ops | -0.71 | -1.41 | -2.41 | -3.57 | 0.15 |
| EPS Diluted Continuous Ops | -0.71 | -1.41 | -2.41 | -3.57 | 4.98 |
| EPS Diluted Before Non-Recurring Items | -0.71 | -1.41 | -2.41 | -3.78 | N/A |
| EBITDA(a) | $-42,211 | $-51,677 | $-60,149 | $-48,336 | $-31,747 |